← Leaderboards
Archana Radhakrishnan
University Of Michigan At Ann Arbor
$1,222,893
Attributed
$1,222,893
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $244.8K · FY2019–23$250K$187.5K$125K$62.5K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,222,893 · 1
By mechanism
K08$1,222,893 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Laura Beretta$16,561,253
- Arul M Chinnaiyan$35,112,976
- Laurence H Baker$13,775,401
- Steven J. Katz$12,985,075
- Todd M. Morgan$1,965,373
Others in their field
Other Emerging Leaders on “Diagnosis”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$141,100,782
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
Research focus
DiagnosisDisease ManagementActive LearningDiabetes MellitusBreastAnxietyCancer DiagnosisAwardCancer RiskAdherenceCare DeliveryCareerCareer DevelopmentCancer CareCaringCase StudyChronic DiseaseCancer PatientComorbidityComplexCare CoordinationDesignDevelopment PlansEnsure
Grant awards (5)
Engaging PCPs to optimize active surveillance of low-risk prostate cancer$244,841
K08 · FY2023 · CA · contact PI
Engaging PCPs to optimize active surveillance of low-risk prostate cancer$244,841
K08 · FY2022 · CA · contact PI
Engaging PCPs to optimize active surveillance of low-risk prostate cancer$244,437
K08 · FY2021 · CA · contact PI
Engaging PCPs to optimize active surveillance of low-risk prostate cancer$244,033
K08 · FY2020 · CA · contact PI
Engaging PCPs to optimize active surveillance of low-risk prostate cancer$244,741
K08 · FY2019 · CA · contact PI